Treatment plans are one of the most important clinical documents completed in behavioral health. They provide a structured roadmap that connects a client’s diagnosis, symptoms, strengths, and treatment needs to measurable goals, evidence-based interventions, and ongoing progress monitoring. Because borderline personality disorder (BPD) involves significant emotional pain, elevated risk, and a history of clinical misunderstanding, a well-written treatment plan helps ensure therapy remains structured, collaborative, and clinically appropriate.
Creating an effective Borderline Personality Disorder treatment plan involves much more than listing a few goals. It requires a comprehensive understanding of the client’s specific symptom pattern, functional impairment, safety needs, and the structured, evidence-based approaches most likely to support meaningful change. A strong treatment plan also demonstrates medical necessity, facilitates communication between providers, and creates objective benchmarks that make it easier to evaluate progress over time. This guide is informed primarily by the 2024 American Psychiatric Association Practice Guideline for the Treatment of Patients With Borderline Personality Disorder and DSM-5-TR, supplemented by NICE’s guideline on borderline personality disorder recognition and management where it offers additional detail (Keepers et al., 2024; American Psychiatric Association, 2022; National Institute for Health and Care Excellence, 2009).
In this guide, we’ll walk through how to create an evidence-based BPD treatment plan, discuss what information should be included, provide practical examples of treatment goals and objectives, and review common documentation considerations for mental health professionals. Whether you’re a student, intern, or experienced clinician, these examples can serve as a starting point for developing individualized treatment plans that reflect each client’s unique presentation.
Key Takeaways
- BPD treatment plans should be individualized. Effective plans connect the client’s specific symptom pattern, functional impairment, and safety needs to measurable goals rather than relying on generic or stigmatizing documentation.
- Contrary to outdated assumptions that BPD is untreatable, current guidance emphasizes that BPD symptoms can improve substantially with structured, evidence-based treatment, and many people experience significant symptom remission over time.
- Several structured psychotherapies—including Dialectical Behavior Therapy (DBT), Mentalization-Based Treatment (MBT), Transference-Focused Psychotherapy (TFP), and Good Psychiatric Management (GPM)—have evidence for reducing core BPD symptoms; no single approach has been established as uniformly superior to the others.
- Medication does not treat the core symptoms of BPD and is not the primary treatment; current guidance recommends psychotherapy as the primary treatment, with medication used cautiously and only to target specific symptoms or co-occurring conditions.
- Comprehensive, ongoing risk assessment is essential given elevated rates of self-harm and suicidal behavior associated with BPD, and should be individualized rather than assumed uniformly high or low based on diagnosis alone.
- Add Product to WishlistSale!
- Add Product to WishlistSale!
- Add Product to WishlistSale!
View our Counseling Treatment Plan Template, which corresponds with this guide.
Why Treatment Planning Matters for BPD
Clients with BPD often present with intense emotional pain, unstable relationships, and impulsive behaviors connected to underlying difficulties with emotion regulation. While clients with BPD often share common features—including fear of abandonment, unstable self-image, and affective instability—every client’s specific symptom presentation, functional impairment, and history is different. Effective treatment planning helps clinicians organize assessment findings into a personalized course of treatment that reflects the client’s specific presentation rather than a generic or stigmatizing template.
A comprehensive treatment plan also serves several important clinical and administrative purposes. It supports continuity of care, promotes collaboration between providers, documents medical necessity for third-party payers, and creates measurable outcomes that can be reviewed throughout treatment. Rather than functioning as a static document completed during intake, treatment plans should be reviewed and updated regularly as the client’s symptoms improve, new challenges emerge, or treatment priorities change.
Whenever possible, treatment planning should be a collaborative process. Current guidance emphasizes engaging the client in a collaborative relationship and shared decision-making about their treatment plan (Keepers et al., 2024). Involving clients in selecting meaningful goals often increases motivation and treatment engagement. Instead of focusing solely on symptom reduction, treatment plans should also build upon the client’s existing strengths and support system.
Complete a Thorough Clinical Assessment Before Writing the Treatment Plan
A treatment plan should never be developed in isolation. Before identifying goals or selecting interventions, clinicians should complete a comprehensive assessment to better understand the client’s presenting concerns, symptom history, psychosocial background, current level of functioning, and diagnostic picture. Information gathered during the intake assessment provides the clinical foundation for every section of the treatment plan.
For clients presenting with possible BPD, current guidance identifies a consistent set of assessment elements: the reason the client is presenting for evaluation, the client’s own goals and preferences for treatment, a review of psychiatric symptoms including core personality-disorder features and common co-occurring disorders, a psychiatric treatment history, an assessment of physical health, an assessment of psychosocial and cultural factors, a mental status examination, and an assessment of risk of suicide, self-injury, and aggressive behavior (Keepers et al., 2024). A quantitative measure of BPD symptom severity is not required for every treatment plan, but can supplement clinical assessment and establish a baseline for monitoring change over time; symptom measures, functional measures, and risk measures serve distinct purposes and shouldn’t be treated interchangeably. In addition to identifying symptoms, clinicians should evaluate common co-occurring conditions, including mood disorders, PTSD, anxiety disorders, ADHD, substance use disorders, and eating disorders, since these frequently accompany BPD and affect treatment planning.
If you are looking for additional guidance on collecting assessment information before creating a treatment plan, our guides to the Counseling Intake Assessment and Biopsychosocial Assessment provide more detailed recommendations for conducting comprehensive evaluations.
Develop a Clinical Formulation Before Creating Treatment Goals
One of the most valuable steps in treatment planning is developing a clinical formulation before writing goals and objectives. Diagnosis, formulation, and treatment planning serve distinct purposes: diagnosis identifies the disorder the client meets criteria for; formulation explains the individual’s maintaining factors, vulnerabilities, strengths, and treatment targets; and treatment planning translates that formulation into measurable goals, objectives, interventions, and monitoring. A thoughtful formulation helps ensure that treatment remains individualized rather than relying on generic goals that could apply to nearly any client.
For clients experiencing BPD, consider the client’s specific pattern of emotional dysregulation, interpersonal instability, and impulsivity; the situations and relationships that most reliably trigger distress; the function that self-damaging or impulsive behaviors may serve (such as reducing overwhelming emotional pain); co-occurring conditions; and the client’s existing coping skills and support system. A biosocial framework—viewing emotional dysregulation as arising from the interaction between biological sensitivity and an invalidating environment—is a useful clinical framework closely associated with DBT specifically, not an established universal causal explanation for BPD; formulation should reflect the individual client’s history rather than assuming a single environmental cause applies to everyone.
A strong clinical formulation naturally guides treatment planning. For example, if a client’s self-harm functions to regulate overwhelming emotion in the absence of other coping skills, treatment should directly build alternative emotion regulation and distress tolerance skills rather than focusing narrowly on eliminating the behavior alone. The treatment plan should clearly demonstrate how the selected interventions address the mechanisms contributing to the client’s symptoms.
Many treatment plans remain superficial because they list symptoms and interventions without explaining the clinical reasoning connecting the two. A strong formulation demonstrates why specific goals were prioritized, why certain interventions were selected, and how the client’s diagnosis, history, strengths, and barriers influence the treatment approach.
Establish Medical Necessity Through Functional Impairment
Treatment plans should document more than the presence of BPD symptoms. They should clearly explain how those symptoms interfere with the client’s daily functioning. Medical necessity is ultimately determined according to the applicable payer’s, jurisdiction’s, and service setting’s own requirements; this guide describes documentation principles that can help support that determination, not wording that guarantees reimbursement. Documenting clinically significant functional impairment can help support medical necessity determinations, but requirements vary by payer, jurisdiction, service type, and clinical setting, and documenting impairment alone does not automatically establish or guarantee medical necessity for every payer.
Rather than simply documenting that a client has “unstable relationships,” describe the observable consequences of their symptoms across relevant domains: occupational functioning, education, relationships, housing stability, financial stability, self-care, healthcare utilization (such as emergency department visits or hospitalizations), legal concerns when relevant, and the client’s ability to maintain consistent engagement in treatment. Examples may include repeated job loss connected to interpersonal conflict, relationship instability affecting custody or housing, emergency department visits following self-harm, or academic disruption connected to impulsive decision-making. These examples create a stronger clinical picture than documenting symptom severity alone.
Whenever possible, establish a measurable baseline before treatment begins. A standardized symptom measure, combined with documented frequency of self-harm or crisis episodes and functional status across relevant life domains, can assist clinicians in assessing severity and monitoring changes over time when used as part of a broader clinical evaluation.
Creating SMART Borderline Personality Disorder Treatment Goals
Effective treatment goals should be individualized, collaborative, and measurable. One of the most common documentation mistakes is writing goals that are too broad to evaluate objectively. Statements such as “reduce instability” or “improve relationships” provide little guidance for future treatment sessions and make it difficult to determine whether meaningful progress has occurred.
Instead, treatment goals should follow SMART principles whenever clinically appropriate. Goals should be specific, measurable, achievable, relevant, and time-bound, though not every goal requires an arbitrary numeric reduction target—numeric targets should be based on the client’s actual baseline and clinically appropriate expectations, and some goals are better measured through frequency, intensity, duration, standardized measures, functional outcomes, skill use, or clinician- and client-rated progress. Objectives should identify observable behaviors or changes that demonstrate movement toward the larger treatment goal, including a measurement method and timeframe whenever clinically appropriate.
Treatment priorities should be individualized, but when acute safety concerns are present, life-threatening behaviors and significant safety concerns generally warrant priority over lower-order quality-of-life targets. At the same time, BPD treatment planning should not become exclusively a symptom- or self-harm-reduction document once safety is established; meaningful quality-of-life goals—such as employment, education, relationships, self-care, identity development, and community functioning—are a legitimate and often central part of the plan.
| Weak Goal | Stronger SMART Goal |
|---|---|
| Reduce instability. | Reduce self-harm episodes from a baseline of 3–4 weekly to 1 or fewer weekly within 12 weeks, tracked via diary card. |
| Improve relationships. | Practice one identified interpersonal effectiveness skill in at least 2 real relationship conflicts weekly, tracked via diary card, within 8 weeks. |
| Manage emotions better. | Use an identified distress tolerance skill in at least 3 of 5 documented crisis moments weekly, reducing reliance on impulsive behavior, within 10 weeks. |
| Stop being impulsive. | Identify and interrupt impulsive urges using a specific skill before acting in at least half of tracked urge episodes within 8 weeks. |
Breaking larger goals into smaller objectives also allows clinicians to recognize incremental progress throughout treatment. These measurable objectives become valuable reference points during treatment plan reviews and progress note documentation.
BPD Treatment Goal Examples
The following BPD treatment goal examples are designed to help mental health professionals develop individualized treatment plans based on each client’s diagnosis, symptoms, functional impairment, strengths, and treatment needs. Effective treatment goals should be collaborative, measurable, and connected to specific objectives and interventions that support meaningful clinical progress. These examples can be adapted based on the client’s specific presentation and treatment setting.
Goal 1: Reduce Self-Harm and Increase Safety
Long-Term Goal: Client will reduce self-harm frequency and suicidal risk, increase use of replacement coping skills, and improve crisis-management capacity. These are related but distinct outcomes that should be tracked separately rather than treated as interchangeable: a reduction in self-harm frequency does not by itself confirm reduced suicide risk, and improved crisis-management capacity (e.g., successfully using a skill or reaching out for support during a crisis) is a meaningful outcome even during a period when self-harm frequency hasn’t yet changed.
Possible Objectives:
- Complete a diary card or self-monitoring log tracking urges, self-harm episodes, suicidal ideation, and skill use daily.
- Collaboratively develop and use a written safety plan, distinct from and reviewed alongside the ongoing risk assessment, updated regularly.
- Identify and use at least one distress tolerance skill during a documented crisis moment weekly, tracked via diary card.
- Contact an identified support person or crisis resource before acting on self-harm or suicidal urges, when needed, tracked via diary card.
Possible Interventions:
- Individual therapy targeting self-harm and suicidal behavior as an explicit treatment priority.
- Distress tolerance and crisis survival skills training.
- Collaborative safety planning, updated as clinically indicated.
- Between-session phone or message coaching for skill generalization, when part of the treatment model.
Goal 2: Improve Emotion Regulation
Long-Term Goal: Client will demonstrate increased ability to identify and regulate intense emotions without resorting to impulsive or self-damaging behavior.
Possible Objectives:
- Identify and name specific emotions in real time, tracked via diary card, at least daily.
- Practice an identified emotion regulation skill in at least 3 real situations weekly, tracked via diary card.
- Reduce impulsive behaviors (e.g., substance use, reckless spending) connected to emotional overwhelm, tracked via self-monitoring log noting frequency and intensity.
- Reduce the time needed to return to baseline functioning after an intense emotional episode (recovery time), tracked via diary card and reviewed in session.
Possible Interventions:
- Emotion regulation skills training.
- Cognitive and behavioral strategies targeting the connection between emotional triggers and impulsive responses.
- Regular review of diary card data to identify patterns and reinforce skill use.
- Psychoeducation regarding emotional sensitivity and regulation.
Goal 3: Improve Interpersonal Functioning
Long-Term Goal: Client will demonstrate improved stability and satisfaction in relationships, with reduced reliance on extreme responses to perceived conflict or abandonment.
Possible Objectives:
- Describe specific, observed interpersonal patterns (for example, rapid shifts between very positive and very negative views of a relationship, when clinically applicable) connected to relationship instability, without presuming the client’s behavior is intentional.
- Practice an identified interpersonal effectiveness skill in at least 2 real relationship situations weekly, tracked via diary card.
- Reduce a specific identified relationship-affecting behavior, tracked via self-monitoring log.
- Report increased satisfaction or stability in at least one identified relationship, reviewed in session.
Possible Interventions:
- Interpersonal effectiveness skills training.
- Exploration of relationship patterns and their connection to fears of abandonment.
- Role-play or rehearsal of specific communication strategies.
- Family or couples sessions when clinically appropriate and consented to by the client.
Remember that these examples are intended as starting points rather than standardized treatment plans. Effective treatment planning requires ongoing collaboration with clients and should reflect their diagnosis, symptoms, strengths, cultural considerations, and treatment preferences. Objectives, interventions, and review dates should be modified as clients make progress or new treatment priorities emerge.
What to Include in a Borderline Personality Disorder Treatment Plan
A comprehensive Borderline Personality Disorder treatment plan should do more than identify symptoms and list interventions. Effective treatment planning creates a clinical roadmap that connects the client’s diagnosis, presenting concerns, functional impairment, strengths, treatment goals, measurable objectives, and selected interventions.
While treatment plan requirements vary depending on clinical setting, payer expectations, state regulations, and organizational policies, many evidence-informed treatment plans include several core elements that support clinical decision-making, continuity of care, and ongoing measurement of treatment progress. Current guidance recommends that a client with BPD have a documented, comprehensive, person-centered treatment plan (Keepers et al., 2024).
A comprehensive BPD treatment plan template typically includes the following clinical documentation sections:
| Treatment Plan Section | Purpose |
|---|---|
| Client and Plan Information | Documents client demographics, treatment plan dates, review dates, treatment plan type, version tracking, clinician information, practice details, session format, frequency, and estimated length of treatment. |
| Coordinating Providers and Services | Identifies other providers, agencies, referrals, releases of information, and care coordination plans to support continuity of treatment. |
| Diagnostic Summary | Documents current diagnoses, ICD-10-CM codes, specifiers, diagnostic considerations, rule-outs, diagnosis changes, and the specific symptoms, duration, severity, and functional impact supporting the diagnosis. |
| Clinical Formulation and Treatment Rationale | Explains the clinician’s understanding of contributing factors, symptom triggers, strengths, protective factors, barriers to treatment, and the clinical reasoning behind selected goals and interventions. |
| Medication and Concurrent Treatment | Documents current medications, prescribing providers, medication response, adherence concerns, and other behavioral health or medical services involved in care. |
| Presenting Problems and Functional Impact | Describes the client’s symptoms, treatment needs, symptom domains, and the impact of BPD symptoms on work, relationships, self-care, safety, and daily functioning. |
| Treatment Goals and Objectives | Establishes individualized long-term goals and measurable short-term objectives, each with its own baseline severity, current functioning, interventions, clinical rationale, and progress tracking. |
| Treatment Modality and Interventions | Documents the primary treatment modality, overall clinical rationale, planned evidence-based interventions, frequency, and between-session assignments. |
| Risk Assessment and Safety Planning Summary | Summarizes relevant risk factors, historical and current safety concerns, protective factors, risk level, and existing safety planning when clinically indicated. |
| Family, Support, and Collateral Involvement | Documents family participation preferences, collateral contacts, cultural considerations, community supports, and other resources involved in treatment. |
| Transition and Discharge Planning | Defines discharge criteria, estimated treatment completion, readiness for transition, aftercare planning, and referrals for continued support. |
| Plan Review and Signatures | Documents treatment plan updates, overall progress, client participation, signatures, supervision requirements when applicable, and record completion. |
The following sections provide a detailed overview of each component and explain how clinicians can use these elements to create treatment plans that are clinically meaningful, individualized, and responsive to client needs.
1. Client and Plan Information
The first section establishes essential identifying and administrative information while creating a clear record of the treatment episode. Clinicians typically document client information, treatment plan dates, review dates, plan type, clinician information, practice details, session format, session frequency, and the anticipated duration of treatment.
Documenting this information helps establish when treatment began, who is responsible for care, how frequently services are provided, and when the plan should be reviewed. A treatment plan should be considered a living clinical document that changes as the client’s symptoms, goals, functioning, and treatment needs evolve over time.
2. Coordinating Providers and Services
Many clients with BPD also participate in additional healthcare or behavioral health services, and coordination is particularly important given common co-occurring conditions and, in some treatment models, a treatment team involving individual therapy and skills group facilitated by different clinicians. Relevant providers may include psychiatrists or other prescribers, primary care providers, substance use treatment providers, higher or lower levels of care, group therapists, and other treating clinicians, each with clearly defined roles and appropriate releases of information or consent on file.
This section documents other providers and agencies involved in the client’s care, relevant releases of information (ROIs), referral information, and plans for coordination when clinically appropriate. Effective care coordination helps reduce fragmented treatment and supports a consistent approach across providers, which is particularly important for clients whose presentation may otherwise lead to inconsistent responses from different members of a care team. Clinicians treating BPD should have appropriate training and access to supervision or consultation given the complexity of this population; this is a documentation and practice consideration worth noting alongside care coordination rather than a separate treatment component.
3. Diagnostic Summary
The diagnostic summary documents the client’s current diagnosis, applicable ICD-10-CM code, diagnostic considerations, and clinical evidence supporting the diagnosis, consistent with DSM-5-TR criteria (American Psychiatric Association, 2022). BPD requires at least five of nine criteria across a pervasive pattern of instability in relationships, self-image, and affect, along with marked impulsivity, present since early adulthood and across contexts.
A strong diagnostic summary extends beyond simply listing a diagnosis. It should clearly connect the diagnostic conclusion with observable clinical evidence: which specific criteria are met and the client’s functional impairment. Differential diagnosis should be addressed explicitly rather than assumed: BPD’s mood reactivity should be distinguished from the more sustained, episodic mood changes of bipolar disorder, since apparent instability in BPD should not automatically be interpreted as manic or hypomanic episodes; presentations should also be differentiated from PTSD and complex trauma-related presentations, ADHD, substance-related conditions, depressive disorders, and other personality pathology, since these can overlap with or mimic BPD features. Common co-occurring conditions, including depression, PTSD, anxiety disorders, ADHD, and substance use disorders, should also be documented, as they are frequent and affect treatment planning.
4. Clinical Formulation and Treatment Rationale
Clinical formulation is one of the most important components of a comprehensive treatment plan because it explains the clinician’s understanding of why the client is experiencing difficulties and why specific treatment approaches were selected. Rather than documenting isolated symptoms, clinicians should synthesize the client’s specific pattern of emotional dysregulation, interpersonal instability, and impulsivity, along with the function these patterns may serve.
This section should also identify the client’s existing strengths and resources—insight, motivation for treatment, supportive relationships, and periods of greater stability—alongside realistic barriers that may interfere with treatment participation or progress, such as difficulty tolerating the structure of a specific treatment model or ambivalence about giving up behaviors that currently function to manage overwhelming emotion. Formulation language should describe behaviors in terms of their function and the underlying emotional dysregulation, rather than in terms that could be read as blaming or pejorative.
5. Medication and Concurrent Treatment
Current guidance is clear that medication does not treat the core symptoms of BPD and is not the primary or mainstay treatment; psychotherapy is recommended as the primary treatment approach (Keepers et al., 2024). This doesn’t mean medication is never appropriate—it’s worth distinguishing several situations clearly in documentation: medication is not indicated for core BPD pathology itself; it may be used, cautiously and adjunctively to psychotherapy, to target a specific measurable symptom (such as sleep disruption or anxiety); it may be indicated to treat a diagnosed co-occurring condition (such as major depressive disorder or ADHD); and short-term, time-limited prescribing may be considered during an acute crisis, with a clear plan to review and, where appropriate, discontinue it once the crisis resolves (National Institute for Health and Care Excellence, 2009). When medication is used, it should be adjunctive to psychotherapy, time-limited where appropriate, directed at a specific target symptom rather than the diagnosis broadly, and reviewed regularly rather than accumulated into complex, long-term regimens. This section should document medication names, dosages, prescribing providers, the specific target symptom or condition, treatment response, adherence concerns, and recent changes, in coordination with the prescribing provider.
This section may also include other concurrent treatments such as psychiatric care, group skills training when part of the treatment model, medical services, or substance use treatment. Documenting concurrent services provides a more complete picture of the client’s treatment landscape and supports coordinated clinical decision-making.
6. Presenting Problems and Functional Impact
The presenting problems section describes the client’s primary concerns and explains how symptoms interfere with daily functioning. Effective documentation goes beyond stating that a client “has BPD” by describing how specific symptoms interfere with important areas of life.
Clinicians may document impairment related to employment, relationships, self-care, safety, and emotional wellbeing. Whenever possible, documentation should include observable examples of impairment. For example, noting a specific pattern of job loss connected to interpersonal conflict, or documented emergency department visits following self-harm, provides stronger clinical evidence than documenting distress alone.
7. Treatment Goals and Objectives
Treatment goals identify the primary clinical outcomes the client and clinician are working toward throughout treatment. Effective BPD treatment goals should be individualized, clinically meaningful, and connected to the client’s specific symptoms and functional concerns identified during assessment.
Each goal should ideally document its own baseline, target outcome, planned intervention, the responsible provider when more than one clinician is involved, a measurement method, and a review timeframe—this level of specificity is one of the most practically useful habits a clinician can build into BPD treatment planning. Each goal should include its own baseline severity and current functioning—the client’s starting point on relevant symptom measures and functional indicators, along with documented frequency of self-harm or crisis behaviors where relevant. Establishing this reference allows clinicians to evaluate whether interventions are producing meaningful improvement over time. Short-term objectives then break the larger goal into measurable steps, describing observable changes in behavior, skill use, or functioning. Each goal should also document the specific interventions being used to pursue it and the clinical rationale connecting those interventions to the client’s diagnosis, formulation, and presentation, along with how progress toward that goal will be tracked over time.
8. Treatment Modality and Interventions
This section documents the primary treatment modality being used and explains how it supports the client’s treatment goals. Several structured psychotherapies have evidence for reducing core BPD symptoms; current guidance does not identify a single approach as superior to the others, and selection should be individualized (Keepers et al., 2024). These approaches primarily target different aspects of the presentation:
- DBT primarily targets emotion dysregulation, self-harm and suicidal behavior, distress tolerance, and interpersonal effectiveness, using mindfulness as a foundational skill.
- MBT primarily targets mentalizing capacity—the ability to understand one’s own and others’ mental states—particularly under interpersonal stress.
- TFP primarily targets identity integration and interpersonal representations, working with affect and relationship patterns as they emerge within the therapeutic relationship itself.
- GPM emphasizes psychoeducation, case management, interpersonal understanding, and the practical, generalist management of BPD, and is often more accessible for clinicians without specialized modality training.
Modality selection should consider the client’s treatment preference, their specific symptom profile and severity/impairment, their ability and willingness to engage with the model’s structure, available support, the clinician’s training in the specific approach, and treatment availability (Keepers et al., 2024; National Institute for Health and Care Excellence, 2009). DBT, developed by Marsha Linehan, is among the most widely available and extensively studied of these approaches (Linehan, 1993). It’s worth distinguishing comprehensive DBT—typically delivered through a structured combination of individual therapy, skills group, between-session coaching, and a therapist consultation team—from DBT-informed treatment, in which a clinician draws on selected DBT skills without delivering the full model; documentation should reflect which is actually being provided rather than describing skills-based work as comprehensive DBT.
This section should also document between-session assignments designed to extend therapeutic work beyond scheduled appointments, such as diary card completion, skills practice, or safety plan review, depending on the selected modality.
9. Risk Assessment and Safety Planning Summary
Comprehensive, individualized risk assessment is a particularly important component of BPD treatment planning, given elevated rates of self-harm and suicidal behavior associated with the diagnosis at a population level (Keepers et al., 2024). Diagnosis alone does not establish an individual client’s acute suicide risk, and risk assessment should differentiate current or imminent risk from chronic or historical risk rather than treating them as a single rating (National Institute for Health and Care Excellence, 2009). A treatment plan does not replace a comprehensive risk assessment or standalone safety plan, but this section should summarize relevant findings.
Self-harm and suicidal behavior are related but distinct and shouldn’t be conflated: not all self-harm reflects suicidal intent, and clinicians should document the function a self-harm behavior appears to serve (such as emotion regulation) separately from an explicit assessment of suicidal ideation, intent, and plan, rather than assuming intent from the presence of self-injury alone. This section may include current suicidal ideation, intent, and plan; prior suicide attempts and self-injury history; dynamic risk factors and recent changes (such as a relationship loss or increased substance use); access to lethal means where clinically relevant; homicidal ideation; protective factors; overall risk level; the clinician’s response to these findings; and whether a separate safety plan has been completed. Risk should be individualized rather than assumed uniformly elevated or resolved based on diagnosis alone, and reassessed whenever clinically appropriate, including following a crisis, a change in symptoms, or a change in functioning.
A safety plan is a distinct, collaborative intervention rather than the risk assessment itself: risk assessment determines and documents the client’s risk, while a safety plan is developed with the client to identify triggers, early warning signs, coping strategies, support people, and specific steps for accessing crisis services if needed (National Institute for Health and Care Excellence, 2009). The two should be documented separately and reviewed together.
10. Family, Support, and Collateral Involvement
Support systems can play an important role in BPD treatment when involvement aligns with the client’s preferences and clinical needs. Treatment plans may document family participation preferences, collateral contacts, community resources, peer supports, cultural considerations, and other external resources.
Family involvement should be guided by informed consent, confidentiality requirements, and clinical appropriateness. When family or partner relationships are a significant focus of treatment, psychoeducation for family members regarding BPD’s biosocial model can help reduce stigma and improve the support system’s capacity to respond effectively.
11. Transition and Discharge Planning
Transition planning helps clinicians and clients identify what successful treatment progress may look like and establish criteria for moving toward discharge or a lower level of care. Discharge is not simply the absence of symptoms; criteria should reflect sustained improvement, functional stability, the client’s demonstrated ability to use coping and treatment skills independently, appropriate support and aftercare in place, the client’s own readiness, and whether the current level of care remains clinically necessary. This is consistent with the understanding that BPD symptoms can improve substantially with treatment and are not a lifelong, unchanging pattern for most clients.
Discharge and transition to a lower level of care are related but distinct: a client may move from weekly individual therapy to a less frequent, maintenance-focused format without this implying complete absence of BPD symptoms or full discharge from care.
Aftercare planning may include referrals to additional providers, continued lower-intensity treatment, community resources, or follow-up care based on the client’s ongoing needs.
12. Plan Review and Signatures
The final section documents treatment plan review, client participation, signatures, and required approvals. Including client participation reinforces that treatment planning is a collaborative process developed between the client and clinician, consistent with current guidance emphasizing shared decision-making with clients with BPD (Keepers et al., 2024).
Documenting signatures, review dates, updates, and progress summaries provides a clear record that the treatment plan has been discussed, evaluated, and modified as clinically appropriate throughout treatment.
Borderline Personality Disorder Treatment Plan Example
The following example demonstrates how the clinical sections of a BPD treatment plan connect together for a client presenting with recurrent self-harm and relationship instability. This example follows the clinical structure of the TherapyByPro Counseling Treatment Plan template, including diagnostic summary, clinical formulation, functional impairment, measurable treatment goals, baseline severity, treatment objectives, evidence-based interventions, clinical rationale, risk assessment, and progress monitoring.
This example is provided for educational purposes only and should be adapted based on the individual client’s symptoms, diagnosis, treatment preferences, clinical judgment, practice setting, and applicable documentation requirements.
| Section | Example Documentation | Clinical Purpose |
|---|---|---|
| Client & Plan Information | Plan Type: Initial Treatment Plan Service Format: Individual outpatient psychotherapy with weekly skills group Frequency: Weekly individual sessions and weekly skills group Estimated Duration: 6–12 months, with ongoing review Primary Concern: Recurrent self-harm and relationship instability connected to emotional dysregulation and fear of abandonment | Defines the scope of treatment and establishes the context in which the client’s presentation will be addressed, monitored, and reviewed over time. |
| Coordinating Providers and Services | Other Providers: No current psychiatric provider or individual medical treatment. Psychiatric consultation available as clinically indicated. Release of Information: Not currently indicated. Care Coordination Plan: Individual therapist and skills group facilitator will coordinate regularly given the client’s participation in both components of treatment. | Documents coordination between multiple components of a structured treatment model. |
| Diagnostic Summary | Diagnosis: F60.3 — Borderline Personality Disorder Symptoms & Clinical Evidence: Client meets 7 of 9 DSM-5-TR criteria: frantic efforts to avoid abandonment; unstable and intense relationships marked by idealization and devaluation; identity disturbance; impulsivity in spending and substance use; recurrent self-harm; affective instability with marked reactivity; and chronic feelings of emptiness. Pattern is pervasive across relationship, occupational, and daily functioning contexts, with earliest onset reported in adolescence—consistent with, though not established by, adolescent onset alone. Diagnostic Considerations: Mood reactivity is short-lived and reactive to interpersonal events rather than sustained, distinguishing it from a manic or hypomanic episode; presentation is not better explained by bipolar disorder, PTSD, ADHD, or a substance-related condition. Continue monitoring for depressive and anxiety symptoms. | Connects the diagnosis to specific symptoms and functional impairment, documenting the specific criteria supporting the diagnosis rather than a general label. |
| Clinical Formulation & Treatment Rationale | Client’s self-harm appears to function as a way of regulating overwhelming emotional pain in the context of perceived relationship threat. A biosocial framework—high emotional sensitivity interacting with limited alternative coping skills—offers a useful way to understand this pattern clinically, though it is one framework among others rather than a confirmed account of this client’s specific history. Recent escalation is directly connected to a relationship ending, consistent with the client’s broader pattern of fear of abandonment driving both relationship instability and self-harm. Occupational instability and identity distress appear connected to the same underlying pattern of interpersonal reactivity and unstable self-image. Strengths: Supportive sibling, active engagement in seeking treatment, and clear personal motivation to build more stable relationships. Barriers: Self-harm currently functions as one of the client’s few available coping strategies for overwhelming emotion, which may create initial ambivalence about reducing it before alternative skills are established. Treatment Rationale: Comprehensive DBT was selected given its structured approach to reducing self-harm as an explicit treatment target while directly building emotion regulation and interpersonal effectiveness skills; other structured approaches (MBT, TFP, GPM) could also be clinically appropriate and were discussed with the client, consistent with current guidance that does not identify one approach as superior (Keepers et al., 2024; Linehan, 1993). | Explains the clinical reasoning connecting the client’s specific symptom function, strengths, and barriers to the selected approach, without presenting the formulation framework or modality choice as the only correct option. |
| Medication and Concurrent Treatment | Current Medication: None; client is not currently taking psychiatric medication. Consideration: Medication is not part of the current treatment plan; psychotherapy is the primary treatment approach. Psychiatric consultation remains available to the client if a specific target symptom or co-occurring condition warrants evaluation. | Documents current medication status consistent with guidance that psychotherapy, not medication, is the primary treatment for BPD. |
| Presenting Problems & Functional Impact | Presenting Problem: Recurrent self-harm and relationship instability connected to fear of abandonment and emotional dysregulation. Functional Impact: Recent emergency department visit; job loss from two positions in the past year connected to interpersonal conflict; chronic feelings of emptiness and identity distress affecting daily functioning. | Demonstrates functional impairment tied specifically to the client’s symptom pattern rather than a general description. |
| Treatment Goals and Objectives | Goal 1 (Safety Priority) — Baseline Severity: Self-harm episodes occurring 3–4 times in the past week; no current suicidal intent or plan reported. Long-Term Goal: Client will reduce self-harm frequency, and demonstrate increased use of distress tolerance skills and improved crisis-management capacity, within 12 weeks. Objective 1: Client will complete a daily diary card tracking urges, self-harm episodes, suicidal ideation, and skill use. Objective 2: Client will identify and use at least one distress tolerance skill during a documented crisis moment weekly, with a goal of reducing self-harm episodes from 3–4 to 1 or fewer weekly, individualized to this baseline. Goal-Specific Interventions: Weekly individual DBT sessions targeting self-harm as a primary treatment focus, concurrent DBT skills group covering distress tolerance and emotion regulation modules, and diary card review each session. Provider: primary individual DBT therapist, coordinating with skills group facilitator. Clinical Rationale for This Goal: This goal was prioritized first given the presence of recent self-harm and an emergency department visit; interventions target the client’s limited alternative skills for managing overwhelming emotion. Goal Progress: Weekly diary card review of self-harm frequency and skill use; standardized symptom measure readministered at 6 and 12 weeks; reassess at 6-week mark and revise the safety plan and treatment approach if self-harm frequency shows no meaningful change or escalates.Goal 2 (Quality of Life) — Baseline: Job loss from two positions in the past year; client reports significant distress about occupational instability and identity. Long-Term Goal: Once safety-related goals show initial progress, client will identify a plan for more stable occupational engagement and report reduced distress connected to identity uncertainty, within 16 weeks. Objective: Client will identify at least one specific value or interest to explore related to work or identity, reviewed in session, and take one concrete step toward it monthly. Goal-Specific Interventions: Exploration of identity and values within individual DBT sessions once initial safety goals are underway; referral to vocational or occupational support as clinically indicated. Clinical Rationale for This Goal: Addressing only self-harm and relationships would leave a significant source of the client’s distress and functional impairment unaddressed; this goal is sequenced after initial safety stabilization consistent with prioritizing life-threatening behaviors first. Goal Progress: Reviewed monthly in session; reassessed collaboratively as Goal 1 progresses. | Establishes the clinical problem, the client’s baseline, and the full reasoning chain from measurable objectives through interventions to a progress-tracking method, while demonstrating how safety-priority and quality-of-life goals are sequenced rather than treated as interchangeable. |
| Treatment Modality and Interventions | Primary Modality: Comprehensive DBT, weekly individual sessions with concurrent weekly DBT skills group and between-session phone coaching, consistent with the full DBT model rather than DBT-informed skills work alone. Between-Session Assignments: Daily diary card completion; skills practice assigned each session; brief phone coaching available for skill generalization between sessions, consistent with the standard DBT model. | Documents the overall treatment approach and specifies that comprehensive DBT, not simply DBT-informed skills training, is being delivered — distinct from the goal-specific interventions above. |
| Risk Assessment & Safety Planning Summary | Current/Imminent Risk: Client denies current suicidal ideation, intent, or plan. Self-harm episodes (3–4 in the past week) appear to function as emotion regulation rather than a suicide attempt, based on the client’s own report; this function was assessed and documented separately from suicidal intent. Chronic/Historical Risk: Recurrent self-harm since adolescence, escalating during interpersonal conflict; no prior suicide attempts reported. Dynamic Factors: Recent relationship ending; increased self-harm frequency this week. Safety Plan: A collaborative written safety plan, distinct from this risk assessment, was developed at intake, identifying triggers, early warning signs, coping strategies, support contacts, and steps for accessing crisis services if needed. Protective Factors: Supportive sibling, engagement in treatment, and stated motivation for change. Risk will be reassessed weekly given the current elevation in self-harm frequency. | Documents individualized, current risk assessment that distinguishes imminent from chronic risk and self-harm’s function from suicidal intent, with the safety plan documented as a related but separate intervention. |
| Family, Support, and Collateral Involvement | Support System: Client identifies their sibling as a significant source of support. Collateral Involvement: Not currently indicated; client is an adult managing their own care, though family psychoeducation may be considered collaboratively if the client requests it. | Documents relevant support context appropriate to an adult client’s autonomy and current treatment needs. |
| Transition and Discharge Planning | Discharge Criteria: Sustained reduction in self-harm, demonstrated independent use of emotion regulation and distress tolerance skills, improved occupational and relationship stability, and the client’s own readiness, along with a determination that continued weekly care is no longer clinically necessary. Aftercare Plan: Consider transition to less frequent, maintenance-focused sessions once stability is sustained, rather than full discharge; continued access to crisis resources as needed. | Establishes realistic, individualized expectations for treatment progress, distinguishing transition to a lower level of care from complete discharge. |
| Plan Review and Signatures | Progress Status: To be reviewed at week 6. Client Participation: Treatment goals, formulation, and safety plan were reviewed collaboratively with the client. Client signature obtained to confirm participation in treatment planning. | Demonstrates collaborative treatment planning and establishes a defined review point. |
BPD Treatment Plan Template
The images below provide a preview of TherapyByPro’s Counseling Treatment Plan template, designed for mental health professionals who need a structured framework for documenting BPD treatment goals, measurable objectives, clinical formulation, interventions, risk considerations, and treatment progress.
The template follows a comprehensive clinical structure that can be adapted for clients receiving DBT, MBT, TFP, GPM, or another structured, evidence-based approach to BPD. It includes sections for client and plan information, care coordination, diagnostic summary, clinical formulation, medication and concurrent treatment, presenting problems and functional impairment, treatment goals, objectives, interventions, treatment modality, risk assessment, family and support involvement, discharge planning, and plan review documentation.
Organized across 15 dedicated pages, the editable Word document and fillable PDF allow clinicians to customize documentation based on their practice setting, clinical approach, and documentation requirements while maintaining a consistent treatment planning workflow.
Clinicians seeking a complete treatment planning solution can access TherapyByPro’s Counseling Treatment Plan template. For clinicians who need a streamlined tool focused specifically on documenting treatment goals, objectives, and interventions, the Treatment Plan Goals template provides a simplified format for tracking progress across multiple treatment goals.
Common Documentation Mistakes When Writing a Treatment Plan for BPD
Even experienced clinicians can develop documentation habits that reduce the clinical usefulness of a BPD treatment plan. A strong treatment plan should do more than identify that a client is “unstable”—it should explain the client’s specific symptoms, functional impairment, treatment goals, selected interventions, and measurable indicators of progress.
The following examples highlight common BPD treatment planning mistakes, why they create documentation challenges, and how clinicians can strengthen their documentation approach.
| Common Documentation Mistake | Why It Is a Problem | Example of Weak Documentation | Example of Stronger Documentation |
|---|---|---|---|
| Using stigmatizing or pejorative language | Describing behaviors as “manipulative” or “attention-seeking” reflects outdated assumptions rather than the current understanding of BPD as rooted in emotional dysregulation, and can affect the quality of care the client receives from other providers who read the chart. | “Client is manipulative and attention-seeking.” | “Client’s behavior appears to function as an attempt to communicate distress and regulate overwhelming emotion in the context of perceived abandonment.” |
| Writing goals that are too broad or difficult to measure | Broad goals make it difficult to evaluate whether self-harm, emotion regulation, and relationship functioning are improving. | “Client will be more stable.” | “Client will reduce self-harm episodes from 3–4 weekly to 1 or fewer weekly within 12 weeks, tracked via diary card.” |
| Treating BPD as untreatable in the documentation’s tone | Current guidance emphasizes that BPD symptoms can improve substantially with treatment; documentation that implies a fixed, unchanging course misrepresents the client’s prognosis and can affect the care they receive elsewhere. | “Client has a personality disorder and is unlikely to change.” | “Client is engaged in structured, evidence-based treatment associated with significant symptom improvement over time for many individuals with this diagnosis.” |
| Assuming uniform risk level based on diagnosis alone | BPD is associated with elevated population-level risk, but individual risk varies significantly and should be assessed directly rather than assumed from the diagnosis. | “Client has BPD, so risk is high.” | “Client denies current suicidal intent or plan; self-harm frequency has increased this week, warranting weekly risk reassessment and safety plan review.” |
| Failing to establish baseline severity and current functioning | Without baseline information, clinicians have limited ability to demonstrate treatment response or meaningful clinical change. | “Client engages in self-harm.” | “Client reports self-harm episodes occurring 3–4 times in the past week, connected to a recent relationship ending.” |
| Overstating medication’s role in treatment | Current guidance is explicit that medication does not treat BPD’s core symptoms and is not the primary treatment; documentation that centers medication can misrepresent the evidence-based approach. | “Treatment plan: medication management for BPD.” | “Psychotherapy is the primary treatment; medication is not currently indicated and would only be considered to target a specific symptom or co-occurring condition.” |
| Neglecting client strengths and existing coping resources | Strengths-based documentation identifies resources that support treatment engagement and resilience. | “Client is in crisis and overwhelmed.” | “Client demonstrates active engagement in seeking treatment, a supportive sibling relationship, and clear motivation to build skills for managing distress.” |
| Confusing a treatment modality with a specific intervention | “DBT” names the overall treatment approach; “distress tolerance skills training” is a specific intervention within it. Conflating the two makes it unclear what is actually being delivered. | “Intervention: DBT.” | “Modality: comprehensive DBT. Goal-specific interventions: distress tolerance skills training and diary card review.” |
| Writing goals without a documented baseline | Without a baseline, clinicians and reviewers have no reference point for whether an intervention produced meaningful change, which weakens both clinical usefulness and medical-necessity documentation. | “Goal: reduce self-harm.” | “Baseline: self-harm episodes 3–4 times weekly. Goal: reduce to 1 or fewer weekly within 12 weeks.” |
| Using the diagnosis itself as the treatment rationale | “Client has BPD” explains nothing about why a specific intervention was chosen; the rationale should reference the client’s specific symptoms, functional impairment, and maintaining factors. | “Client has BPD, so DBT was selected.” | “DBT was selected because the client’s self-harm functions to regulate overwhelming emotion in the absence of alternative coping skills, which DBT’s distress tolerance module directly targets.” |
| Treating the treatment plan as a static, one-time document | A treatment plan written at intake and never revisited doesn’t reflect the client’s actual course of treatment; measurable progress data should drive periodic updates to goals, objectives, interventions, risk planning, and level-of-care decisions. | “Continue current treatment plan” (unchanged for 6 months). | “Self-harm frequency reduced from 3–4 to 1 weekly; goal updated to consolidate skill use and add an occupational functioning objective.” |
Clinical Note: One of the most common documentation challenges in BPD treatment planning is language that inadvertently reflects outdated stigma rather than the client’s actual clinical presentation. A strong BPD treatment plan connects the client’s specific symptom pattern, functional impairment, safety needs, treatment goals, interventions, and measurable outcomes into a cohesive, non-stigmatizing clinical roadmap.
Frequently Asked Clinical Questions
The following frequently asked questions address common clinical documentation considerations for mental health professionals developing BPD treatment plans. These answers provide guidance on treatment goals, measurable objectives, evidence-based interventions, medical necessity, progress monitoring, and other factors clinicians should consider when creating individualized treatment plans for clients with BPD.
How many treatment goals should be included in a BPD treatment plan?
There is no universal requirement for the number of goals included in a BPD treatment plan, but most treatment plans include two to three primary goals that address the client’s most significant symptoms and areas of impairment, often prioritizing safety-related goals first when self-harm or crisis behaviors are present. Additional goals can be added or modified during treatment plan reviews as the client’s needs change.
What is the difference between a treatment goal and an objective?
A treatment goal describes the broader clinical outcome, such as reducing self-harm and increasing emotion regulation. Objectives are the measurable steps used to evaluate progress toward that goal, such as completing a daily diary card or practicing a specific skill a set number of times weekly, tracked with defined frequency and timeframes.
Is DBT the only effective treatment for BPD?
No. While DBT is among the most widely available and extensively studied structured psychotherapies for BPD, current guidance identifies several approaches—including Mentalization-Based Treatment, Transference-Focused Psychotherapy, and Good Psychiatric Management—with evidence for reducing core BPD symptoms, without establishing any single approach as superior (Keepers et al., 2024). Treatment selection should be individualized based on client presentation, preference, and availability.
Should standardized assessments be included in a BPD treatment plan?
Current guidance suggests that the initial psychiatric evaluation include a quantitative measure of BPD symptom severity to support diagnostic clarification and treatment planning (Keepers et al., 2024). Standardized measures can supplement clinical observation and provide a baseline for tracking symptom change over time.
How often should BPD treatment plans be reviewed?
Treatment plan review frequency depends on clinical judgment, organizational policies, state requirements, and payer expectations. Given the elevated risk associated with BPD, more frequent review may be appropriate during periods of self-harm escalation, crisis, or significant symptom change, in addition to any standard review schedule.
Is medication recommended for BPD?
Current guidance is clear that medication does not treat the core symptoms of BPD and is not the primary treatment; psychotherapy is recommended as the primary approach. Medication may be used cautiously and conservatively to target specific symptoms or a co-occurring condition, reviewed regularly, rather than accumulated into a long-term, complex regimen (Keepers et al., 2024).
What should a BPD treatment plan include?
At minimum, a BPD treatment plan should include client and provider information, a diagnostic summary with supporting evidence, a clinical formulation explaining the client’s specific symptom pattern and maintaining factors, medication and concurrent treatment status, functional impairment, measurable treatment goals and objectives, the treatment modality and interventions, a risk assessment and safety planning summary, family/support involvement, transition and discharge criteria, and documentation of plan review and client participation.
What are the primary treatment goals for BPD?
Primary treatment goals typically address reducing self-harm and suicidal risk, improving emotion regulation, and improving interpersonal functioning, with safety-related goals generally prioritized first when acute risk is present. Treatment planning should also include meaningful quality-of-life goals—such as employment, education, and identity development—once safety is established, rather than focusing exclusively on symptom reduction.
How should self-harm be documented in a BPD treatment plan?
Document the frequency, method, and context of self-harm episodes, along with the function the behavior appears to serve (such as emotion regulation), assessed separately from an explicit evaluation of suicidal ideation, intent, and plan. Self-harm should not be assumed to indicate suicidal intent without direct assessment, and a collaborative safety plan should be documented separately from the risk assessment itself.
Should BPD treatment goals focus only on reducing symptoms?
No. While safety-related and symptom-focused goals are often an appropriate early priority, a comprehensive BPD treatment plan should also address functioning, quality of life, relationships, occupational or educational goals, and other personally meaningful outcomes once initial safety and stability are established.
Conclusion: Creating Effective BPD Treatment Plans That Support Meaningful Clinical Progress
An effective BPD treatment plan is more than a compliance form. At its best, it’s a clinical reasoning document that connects assessment to formulation, formulation to measurable goals, goals to specific interventions, and interventions to ongoing measurement and review—documented in language that reflects current clinical understanding rather than outdated stigma.
Current guidance emphasizes that BPD symptoms can improve substantially with structured psychotherapy, and identifies several evidence-based approaches rather than a single required protocol (Keepers et al., 2024). Treatment plans are living documents and should be reviewed and updated as the client’s symptoms, safety needs, and functioning evolve over the course of treatment.
TherapyByPro is a trusted resource for mental health professionals worldwide. Our therapy tools are designed with one mission in mind: to save you time and help you focus on what truly matters-your clients. Every worksheet, counseling script, and therapy poster in our shop is professionally crafted to simplify your workflow, enhance your sessions, reduce stress, and most of all, help your clients.
Want to reach more clients? We can help! TherapyByPro is also a therapist directory designed to help you reach new clients, highlight your expertise, and make a meaningful impact in the lives of others.
- Add Product to WishlistSale!
- Add Product to WishlistSale!
- Add Product to WishlistSale!
References
- American Psychiatric Association. (2022). Diagnostic and Statistical Manual of Mental Disorders (5th ed., text revision; DSM-5-TR). American Psychiatric Association Publishing. Resource
- Keepers, G. A., Fochtmann, L. J., Anzia, J. M., Benjamin, S., Lyness, J. M., Mojtabai, R., Servis, M., Choi-Kain, L., Nelson, K. J., Oldham, J. M., Sharp, C., Degenhardt, A., Hong, S. H., & Medicus, J. (2024). The American Psychiatric Association practice guideline for the treatment of patients with borderline personality disorder. American Journal of Psychiatry, 181(11), 1024–1028. Resource
- Linehan, M. M. (1993). Cognitive-Behavioral Treatment of Borderline Personality Disorder. Guilford Press.
- National Institute for Health and Care Excellence. (2009). Borderline personality disorder: Recognition and management (NICE guideline CG78). Resource